NYSE · Medical - Care Facilities
EHC (EHC) Stock
$122.05
+1.53%
NYSE: EHC
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
EHC: Lowering target price to $120.00
Argus Research · Jul 15, 2026
Encompass Health announces date of 2026 second quarter earnings call
PR Newswire · Jul 9, 2026
Encompass Health (EHC) Stock May Be A Bargain Following Growing Investor Interest
Simply Wall St. · Jul 9, 2026
Encompass Health (EHC) Could Be 12% Overvalued Following Branford Facility Progress
Simply Wall St. · Jul 8, 2026
1 Cash-Producing Stock Worth Your Attention and 2 We Question
StockStory · Jul 8, 2026
Cash Flow (USD)
About EHC
EHC is led by CEO Mark J. Tarr, employs 42,300 people, headquartered in Birmingham, US, publicly traded since 1986.
EHC stock trades at $122.05 with a market capitalization of $12.11B. The stock is valued at a price-to-earnings (P/E) ratio of 18.97, price-to-book of 4.28, price-to-sales of 1.71. Over the past 52 weeks the stock has ranged between $92.77 and $127.99, and currently trades 4.6% below its 52-week high. It pays a dividend yielding 0.71%.
On profitability, EHC generates a return on equity (ROE) of 23.22% — well above the market average, a sign of a high-quality business, return on capital employed of 32.14%, an operating margin of 17.74%, a net profit margin of 10.04%.